Studie 17 pacientů postižených plexiformními neurofibromy na horních a dolních končetinách: srovnání různých chirurgických technik


Autoři: M. G. Onesti ;  S. Carella ;  G. Spinelli ;  A. Martano ;  S. Giustini ;  N. Scuderi
Působiště autorů: Department of Dermatology and Plastic Reconstructive Surgery, University of Rome “Sapienza”, Rome, Italy
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 51, 2, 2009, pp. 35-40


Zdroje

1. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol., 6, 2007, p. 340-351.

2. Darrigo LG. Jr., Geller M., Filho AB., Azulay DR. Prevalence of plexiform neurofibroma in children and adolescents with type I neurofibromatosis. J. Pediatr. (Rio J), 83, 2007, p. 571-573.

3. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Arch. Neurol., 45, 1988, p. 575-578.

4. Daston MM., Scrable H., Nordlund M. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron, 8, 1992, p. 415-428.

5. Evans DG., Baser ME., McGaughran J. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J. Med. Genet., 39, 2002, p. 311-314.

6. Ferner RE., Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumours in neurofibromatosis 1. Canc. Res., 62, 2002, p. 1573-1577.

7. Ferner RE., Huson SM., Thomas N. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J. Med. Genet., 44, 2006, p. 81-88.

8. Listernick R., Louis DN., Packer RJ. Optic pathway gliomas in children with neurofibromatosis type 1: consensus statement from the NF1 optic pathway glioma study. J. Paediatr., 125, 1994, p. 63-66.

9. Lubs ML., Bauer MS., Formas ME. Lisch nodules in neurofibromatosis 1. N. Engl. J. Med., 324, 1991, p. 1264-1266.

10. North KN., Riccardi V., Samango-Sprouse C. Cognitive function and academic performance in neurofibromatosis. 1: Consensus statement from the NF1 Cognitive Disorders Task Force. Neurology, 48, 1997, p. 1121-1127.

11. Tonsgard JH., Kwak SM., Short MP. CT imaging in adults with neurofibromatosis 1: frequent asymptomatic plexiform lesions. Neurology, 50, 1998, p. 1755-1760.

12. Korf BR. Plexiform neurofibromas. Am. J. Med. Genet., 89, 1999, p. 31-37.

13. Agaram NP., Prakash S., Antonescu CR. Deep-seated plexiform schwannoma: A pathologic study of 16 cases and comparative analysis with the superficial variety. Am. J. Surg. Pathol., 29, 2005, p. 1042-1048.

14. Shetty GM., Murari AS., Song HR., Lee SH., Yang JH. Neurofibromatous sensory neuropathy of the thigh in a 7-year-old boy. Arch. Orthop. Trauma Surg., 128, 2008, p. 1093-1097.

15. Salazar F., Machado A., Murthy S., Boulis NM. Thoracoscopically guided transaxillary resection of adjoining intercostal plexiform neurofibromas: review of mosaicism in neurofibromatosis: technical note. Neurosurgery, 57 (4 Suppl.), 2005, E407; discussion E407.

16. Wise JB., Cryer JE., Belasco JB., Jacobs I., Elden L. Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1. Arch. Otolaryngol. Head Neck Surg., 131, 2005, p. 712-718.

17. Blitz NM., Hutchinson B., Grabowski MV. Pedal plexiform neurofibroma: review of the literature and case report. J. Foot Ankle Surg., 41, 2002, p. 117-124.

18. Kraus DH. Management issues in massive pediatric facial plexiform neurofibroma with neurofibromatosis type 1. Head Neck, 24, 2002, p. 207-211.

19. Nagel A., Greenebaum E., Singson RD., Rosenwasser MP. McCann PD. Foot drop in a long-distance runner. An unusual presentation of neurofibromatosis. Orthop. Rev., 23, 1994, p. 526-530.

20. Weiss SW. et al. Neural tumours. In: Weiss SW. et al. Histological typing of soft tissue tumours. Springer: Berlin Heidelberg New York, 1994, p. 38-39.

21. Iannicelli E., Rossi G., Almberger M., Drudi FM., Giustini S., Calvieri S., David V. Integrated imaging in peripheral nerve lesions in type 1 neurofibromatosis. Radiol. Med. (Torino), 103, 2002, p. 332-343.

22. Friedrich RE., Korf B., Funsterer C., Mautner VF. Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res., 23, 2003, p. 949-952.

23. Friedrich RE., Schmelzle R., Hartmann M., Mautner VF. Subtotal and total resection of superficial plexiform neurofibromas of face and neck. J. Craniomaxillofac. Surg., 33, 2005, p. 55-60.

24. Nahabedian MY., Rozen SM., Namnoum JD., Vander Kolk CA. Giant plexiform neurofibroma of the back. Ann. Plast. Surg., 45, 2000, p. 442-445.

25. Salazar R., Robotti EB., Chin DHL., Grossman JAI. Giant neurofibromatosis of the chest wall: two patient reports. Ann. Plast. Surg., 41, 1998, p. 211-221.

26. Park BY., Hong JP., Lee WJ. Netting operation to control neurofibroma of the face. Plast. Reconstr. Surg., 109, 2002, p. 1228-1236.

27. Neville HL., Seymour-Dempsey K., Slopis J., Gill BS., Moore BD., Lally KP., Andrassy RJ. The role of surgery in children with neurofibromatosis. J. Pediatr. Surg., 36, 2001, p. 25-29.

28. Pu LLQ., Vasconez HC. Large recurrent plexiform neurofibroma of the foot and ankle. Microsurgery, 24, 2004, p. 67-71.

29. Jackson IT., Carbonnel A., Potparic Z., Shaw K. Orbitotemporal neurofibromatosis: classification and treatment. Plast. Reconstr. Surg., 92, 1993, p. 1-11.

30. Friedrich RE., Schmelzle R., Hartmann M., Fünsterer C., Mautner VF. Resection of small plexiform neurofibromas in neurofibromatosis type 1 children. World. J. Surg. Oncol., 3, 2005, p. 6.

31. Tanaka J., Kuramochi A., Nishi N., Yuasa M., Heshiki A. Preoperative transarterial embolization enhances the surgical management of diffuse plexiform neurofibroma: A case report. Cardiovasc. Intervent. Radiol., 28, 2005, p. 686-688.

Štítky
Chirurgie plastická Ortopedie Popáleninová medicína Traumatologie

Článek vyšel v časopise

Acta chirurgiae plasticae

Číslo 2

2009 Číslo 2

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Cesta pacienta s CHOPN
nový kurz
Autoři: doc. MUDr. Vladimír Koblížek, Ph.D.

Arteriální hypertenze ve světle nových evropských guidelines
Autoři: MUDr. Libor Jelínek

Precizní medicína v onkologii
Autoři:

Kožní toxicita cílené terapie inhibitory EGFR a VEGF
Autoři: MUDr. Karolína Svobodová

Jak na psoriázu v každodenní ambulantní praxi?
Autoři: MUDr. Jan Šternberský, Ph. D.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se